Airway Management Market

Airway Management Market Size (2023 to 2028)

The global airway management market is projected to be worth USD 1.69 billion by 2028 from USD 1.22 billion in 2023, growing at a CAGR of 6.67% from 2023 to 2028.

Airway management is used for patients with obstructed airways or at risk of obstructing airways. Airway management devices are mainly used in critical care to improve pre-operative and post-operative stages. For example, the laryngeal mask airways, oropharyngeal airway, tracheal intubation, and nasopharyngeal airways are used on anesthesia patients. In addition, the devices are used in an emergency, hospitals, operating rooms, pre-hospital settings, and out-of-hospital care.

Impact of COVID-19 on the global airway management market:

The arrival of the COVID-19 pandemic made its influence known by early 2020, followed by worldwide lockdowns. As a result, the airborne disease became a significant threat to the economic growth of small and large-scale manufacturers around the globe. Unfortunately, the exponential growth was observed to be directly proportional to the number of patients who suffered and were hospitalized. As a result, the healthcare sector shifted its attention towards providing patients with proper ventilation as low oxygen levels promoted sickness. Air management refers to determining medical procedures to ensure proper respiration in patients and eradicate any barrier proving to block the airway path. These medical procedures are assisted by specialized devices, following guidelines with care and attention. COPD is a standardized name for global Chronic obstructive pulmonary disease, which contributes to the third-leading cause of death, about 3.2 million individuals annually. Respiratory failure was concluded as the typical reason.

The COVID-19 pandemic triggered the sudden rise in respiratory problems, providing ground for other respiratory diseases to germinate. The outbreak is forecasted to provide growth for air management services as the demand and necessity increase. Owing to SARS-CoV-2 {Covid-19} (an airborne virus) only added value to the dying number of patients, as the virus directly affected the lungs, giving rise to nasty diseases such as pneumonia and ARDS. Therefore, the global airway management market progressed due to the pandemic. Acute hypoxemic respiratory failure requires mechanical ventilation. Numerous mechanisms are used in practice for many patients' significant hypoxemia (low level of o2). These include pulmonary enema, hemoglobinopathies, vascular occlusion, and soaring demand for Airway management. 

MARKET DRIVERS:

The growing incidence of acute respiratory failures promotes the airway management market growth. 

The risk of consumption of alcohol, drowning, smoking, and inherited respiratory problems all together becomes the reason for acute respiratory failure. High alcohol exposure significantly increases the risk of ARDS by a ratio of 1.89. An estimated 97% of extended Alcohol drinkers suffer from Acute respiratory failure due to irresponsive cerebellum and brain stem responsible for maintaining heartbeat and respiration.

The increasing toxic drinks consumption is likely to cause greater attention towards airway management by numerous segments.

The habit of smoking is being compelled and discouraged, the awareness program and campaigns are being held despite the effort; smoking kills around 7.7 million, causing deaths – including 1 in 5 deaths in males worldwide. Furthermore, research suggests an established link between smoking and acute respiratory failure. Due to these concerns, the requirement for an airway management system proves necessary, stimulating the extension of the airway management market. Furthermore, the escalating number of road accidents creates an emergency, cutting short approximately 1.3 million people due to reckless driving, including speeding, breaking traffic rules, and mixing drink and driving. The sudden impact on the sensitive cerebellum and other cranial parts can knock a person out of consciousness. Moreover, the damage to the rib cage or cartilage can cause striking damage to the lungs inhibiting oxygen intake and creating a prerequisite for respiratory administration.

MARKET RESTRAINTS:

High costs are one of the major factors hampering the growth of the airway management market. In high demand, the pandemic-influenced cost of medical oxygen cylinders utilized by the healthcare and emergency sectors is costing patients their life savings as each cylinder costs USD 80. As a matter of fact, at a flow rate of 10 liters per minute, the cylinder would last just over 1 hour. On the other hand, the cylinder would last just over two hours at a flow rate of 5 liters per minute.

This research report on the global airway management market has been segmented and sub-segmented based on patient age, procedure, type, application, end-user, and region.

Airway Management Market – By Patient Age:

• Adult
• Paediatric/Neonates

Based on the patient's age, most of the share was accounted for by the adult segment in 2022. Adults suffer more from acute respiratory and other related pulmonary problems, thus creating emergencies. In addition, the senior population is heavily influenced by growing environmental factors and the contribution of declining health with age. The old-age and senior citizens are vulnerable; thus, the data exhibits positive outcomes for market propulsion.

Airway Management Market – By End-User:

• Homecare
• Surgical Centres (ASCs)
• Hospitals
• Operating Rooms
• Emergency Care Department
• Intensive Cares
• Others
• Others

Based on the end-user, the hospitals accounted for the largest share of the market in 2022. On the other hand, the operating rooms segment is anticipated to register healthy growth during the forecast period. The operating rooms sub-segment became a sprouting ground for utilizing and operating the Airway Management in terms of devices due to the rise in the number of patients served.

Airway Management Market – By Procedure:

• Emergency Procedure
• Intensive Care Unit
• Non-Emergency Surgical Procedures

Based on the procedure, the emergency and ICU segments dominated the airway management market in 2022. Owing to the extensive use of airway management devices in ICUs and the increased use of anesthesia and emergency procedures performed in ICUs, the ICU segment is anticipated to register the lead in the future.

Airway Management Market – By Device Type:

• Infraglottic Airway Management Devices
• Bronchoscope/Intubation Scopes
• Supraglottic Airway Management devices
• Resuscitators
• Laryngoscopes
• Others

Based on the device type, the infraglottic airway management devices segment led the market in 2022. The ever-high demand for positive air pressure ventilation resulted in the marketing potential for Infraglottic airway management devices. Furthermore, factors and situations create an emergency ground requiring direct air supply through the trachea into the lungs, increasing the chances of survival. In addition, the prevalence of chronic respiratory diseases and pulmonary complexities pushed the use of such mechanics.

Airway Management Market – By Application:

• Emergency Medicines
• Anesthesia
• Others

Based on the application, the anesthesia segment held the most prominent share of the global market in 2022. It is expected to continue its dominance during the forecast period owing to increased international anesthesia procedures and the rising need to maintain a safe breathing passage to lower anesthesia-related complications during surgeries.

Airway Management Market – By Region:

• North America
• Latin America
• Asia Pacific
• Europe
• Middle East and Africa

The North American region is anticipated to exhibit the exponent of growth factor by a growing CAGR in the global market. The analysis explains a more significant number of hospitals and the enlarging senior population is the cause of concern, promoting grounds for expanding the market. In addition, countries like the U.S. and Canada have high levels of air pollution and airborne diseases along with modern infrastructure and key market players leading to market growth in North America.

The European Airway Management Device Market is expected to generate a significant outcome by 2027. Rapid technological advances and industrial developments are forecasted to propel the market in countries like the U.K., Germany, Italy, and France.

KEY MARKET PLAYERS:

Salter Labs, Teleflex Incorporated, Intersurgical Inc., Medtronic, Roper Technologies (Verathon Inc.), Sunmed, Ambu A/S, Smiths Group PLC, Sourcemark, Vyaire Medical, and Vbm Medizintechnik GmbH are a few of the notable players in the global airway management market and profiled in this report.

RECENT MARKET DEVELOPMENTS:

• In August 2022, Hamilton Medical AG Recalled Hamilton-C6 Intensive Care Ventilator Due to Potential Water Ingress that May Cause Breathing Support to Stop. Intensive Care Ventilator, known by its famous name, The HAMILTON-C6, is extensively utilized to provide mechanical ventilation and breathing support for infants with respiratory difficulties.
• Medtronic plc launched its first airway monitoring system for pediatric patients in May 2021. SonarMed uses acoustic technology to detect ETT obstruction and provides clinicians with essential data to make more informed decisions.
• VBM Medizintechnik GmbH announced receiving 510(k) clearance in September 2020 from the FDA for its ScalpelCric kit.
• Verathon launched the GlideScope Video Baton QC Large in August 2020. This device is a video laryngoscope used with the core airway management devices of GideScope.
• Cerathon launched the GlideScope Core 15 in January 2020; an airway visualization system used to deliver higher visibility with touchscreen features and a high-definition monitor.